Search

Displaying results 6771 - 6780 of 9322 in total
  1. Drug

    Elbimilast

    go.drugbank.com/drugs/DB20663
    Investigational

    The usage of the INN stem '-milast' in the name indicates that Elbimilast is a Phosphodiesterase-4 (PDE4) inhibitor.

  2. Drug

    Telenzepine

    go.drugbank.com/drugs/DB19508
    Investigational

    The usage of the INN stem '-zepine' in the name indicates that Telenzepine is a tricyclic compound.

  3. Drug

    Felezonexor

    go.drugbank.com/drugs/DB21067
    Investigational

    The usage of the INN stem '-nexor' in the name indicates that Felezonexor is a nuclear export inhibitor.

  4. Drug

    Ledaborbactam etzadroxil

    go.drugbank.com/drugs/DB21455
    Investigational

    The usage of the INN stem '-bactam' in the name indicates that Ledaborbactam etzadroxil is a ẞ-lactamase inhibitor.

  5. Drug

    Edaxeterkib

    go.drugbank.com/drugs/DB21490
    Investigational

    The usage of the INN stem '-terkib' in the name indicates that Edaxeterkib is a extracellular signal-regulated kinase (ERK) inhibitor.

  6. Drug

    Icovamenib

    go.drugbank.com/drugs/DB21669
    Investigational

    The usage of the INN stem '-menib' in the name indicates that Icovamenib is a menin interaction inhibitor.

  7. Drug

    Farletuzumab

    go.drugbank.com/drugs/DB05595
    Investigational

    Farletuzumab (MORAb-003) is a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer.

  8. Drug

    Olaparib-bodipy FL

    go.drugbank.com/drugs/DB16263
    Investigational

    Olaparib-bodipy FL is under investigation in clinical trial NCT03085147 (A Dye for the Detection of Cancer of the Tongue and Mouth).

  9. Drug

    Abacavir hydroxyacetate

    go.drugbank.com/drugs/DB12187
    Investigational

    Prurisol is under investigation for the treatment of Chronic Stable Plaque Psoriasis. Prurisol has been investigated for the treatment of Plaque Psoriasis.

  10. Drug

    Nomacopan

    go.drugbank.com/drugs/DB14991
    Investigational

    Nomacopan is under investigation in clinical trial NCT03427060 (Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms).